WiseInvest is the angel investing office of Nikolai Angelov from Estonia. He is entrepreneur, investing into early-stage startups. He has done more than 300 investments into many fields, including but not limited to proptech, fintech, greentech, medtech, and real estate.
Exerte Partners is a family office from Cyprus. They invest generalistically, but have a slight emphasis on food, biotech, energy and SaaS solutions. Their expertise includes scaling and internationalization, as well as optimizing at scale.
They invest typically as a co-investor, but have occasionally lead rounds in cases they know especially well (e.g. food). They don’t generally do convertible notes.
Vestman Energia looks to invest into scalable solutions in energy, food and forestry. In energy they are most interested in distributed generation and storage.
They are typically a co-investor. They have also been a lead investor in cases where they had special expertise.
Swiss Post Ventures is the fund of Swiss Post, who operate a multi-billion euro business in fleet management, public transportation (buses), postal offices, communication services etc., mostly in Switzerland. Swiss Post has 60k employees, Swiss Post Ventures has three people.
They’re looking for startups especially in mobility, logistics, cyber security, communication platforms, and digital health.
The startups they invest into should have some link into Swiss Post’s value chain and ecosystem.
They are often a follow investor, and prefer to invest less than 50% of the round. They have occasionally been a lead investor for a startup whose market they understand exceptionally well.
Hanover 16 is a UK-based family office investing European, US and Israeli companies. They focus especially on health tech, including digital health and pharmaceuticals, agro and food tech, including biotechnologies, next gen farms, and livestock, but are open to other businesses as well. They occasionally review especially interesting hardware cases, but are generally more focused on software, marketplaces and pharma.
They prefer companies with a commercial traction, ideally over 500ke annual revenue. They are typically a co-investor (not lead). They analyze startups in multiple different stages, with a preference for later stages all the way up to pre-IPO rounds.
For deal flow and cooperation please contact: email@example.com
Athensmed is the angel investment company of Kustaa Piha. He’s a veteran of medical technology and digital health, having grown Med Group from 0 to 100Me turnover before exiting it. Since 2016 he has done multiple investments and exits in the health space. He often helps his companies through a board seat, but has occasionally served as a medical director as well.
Fund Fellow Founders is an angel network investing together in interesting deals. Angels in their network have been responsible for business development, sales, technology, legal and other parts of turning tech startups into unicorns. They do investments starting from small rounds up to very large rounds with their VC network.
They are especially interested in health tech, food tech and green tech / cleantech, as well as deep tech. They are interested in other fields as well. They strongly prefer companies that have a clear and reasonably short path to profitability. They prefer companies whose main tech value is in the software side.
Geographically they have no limitations, but seek Nordic-Baltic deals most actively.
Honey Badger is angel syndicate of three founders of PipeDrive, a successful SaaS company from Estonia. They are especially happy to help SaaS companies and cleantech ones, but are also looking for other founders they could help succeed.
They’re most often a co-investor instead of a lead one.
OTB Ventures invest into software and software-enabled hardware startups, where the main value is in the software side. They focus on deep tech or other tech-enabled unique sources of competitive advantage. They’re interested in B2B and B2B2C, with possible exceptions of B2G who know how to sell their product well, and fintech/insurtech B2C.
They invest into companies that have a strong connection to EU – either based in EU in whole or part, or originally from EU, for example. Stage-wise they’re most interested in the scaling phase, with occasional exceptions for especially strong cases with a mature product that is approaching the scaling stage. Most of their investments had approx. 1M ARR at the time of initial investment.
They often lead or co-lead rounds.
Wharton Alumni Angels has approx. 400 members doing angel investments into promising startups globally. Their most active regional clubs are in US, UK & Europe, and Brazil. They prefer tech-enabled companies that have early revenue or other significant indications of their ability to start scalable growth.